Related Experiment Videos
Pleuroperitoneal shunt for intractable pleural effusion
Canadian Journal of Surgery. Journal Canadien De Chirurgie
|November 1, 1984
Summary
Malignant pleural effusions can be difficult to treat. A pleuroperitoneal shunt effectively managed recurrent effusions in a patient with advanced lung cancer, offering an alternative to painful procedures.
Area of Science:
- Pulmonology
- Oncology
- Surgical Innovation
Background:
- Malignant pleural effusion (MPE) poses a significant challenge in palliative care.
- Traditional treatments like thoracentesis and sclerotherapy are invasive and may yield suboptimal results.
- Recurrent MPE necessitates exploring alternative, effective management strategies.
Observation:
- A 73-year-old male patient presented with recurrent right and left MPE due to inoperable squamous cell carcinoma.
- Left-sided MPE management was complicated by a functioning pericardial window, precluding sclerotherapy.
- The patient had a history of right-sided MPE managed previously.
Findings:
- A pleuroperitoneal (LeVeen) shunt was successfully inserted to manage the left-sided MPE.
- This intervention provided an effective alternative to repeated thoracentesis or sclerotherapy.
- The shunt facilitated continuous drainage of pleural fluid into the peritoneal cavity.
Implications:
- Pleuroperitoneal shunts represent a viable and less invasive option for intractable MPE.
- This case highlights the potential of shunts in complex MPE scenarios, including those with prior interventions.
- Further research into shunt efficacy and patient selection for MPE management is warranted.